54 related articles for article (PubMed ID: 15010862)
21. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome].
Chu YL; Sun YY; Qiu HY; Li HF
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):176-9. PubMed ID: 15130378
[TBL] [Abstract][Full Text] [Related]
22. [Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome].
Wang ZC; Gu XF; Yang DZ; Kuang JQ
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):120-3. PubMed ID: 15840294
[TBL] [Abstract][Full Text] [Related]
23. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo.
Rajkhowa M; Brett S; Cuthbertson DJ; Lipina C; Ruiz-Alcaraz AJ; Thomas GE; Logie L; Petrie JR; Sutherland C
Biochem J; 2009 Mar; 418(3):665-71. PubMed ID: 19053948
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.
Jones MR; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
Fertil Steril; 2008 Dec; 90(6):2298-303. PubMed ID: 18249389
[TBL] [Abstract][Full Text] [Related]
27. P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine.
Sun J; Khalid S; Rozakis-Adcock M; Fantus IG; Jin T
Oncogene; 2009 Sep; 28(35):3132-44. PubMed ID: 19581924
[TBL] [Abstract][Full Text] [Related]
28. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
He S; Dibas A; Yorio T; Prasanna G
Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
[TBL] [Abstract][Full Text] [Related]
29. Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells.
Marek L; Levresse V; Amura C; Zentrich E; Van Putten V; Nemenoff RA; Heasley LE
J Cell Physiol; 2004 Dec; 201(3):459-69. PubMed ID: 15389548
[TBL] [Abstract][Full Text] [Related]
30. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
[TBL] [Abstract][Full Text] [Related]
31. Annexin A6 inhibits Ras signalling in breast cancer cells.
Vilá de Muga S; Timpson P; Cubells L; Evans R; Hayes TE; Rentero C; Hegemann A; Reverter M; Leschner J; Pol A; Tebar F; Daly RJ; Enrich C; Grewal T
Oncogene; 2009 Jan; 28(3):363-77. PubMed ID: 18850003
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients.
Rapoport MJ; Mor A; Amit M; Rosenberg R; Ramot Y; Mizrachi A; Wysenbeek AJ
Lupus; 1999; 8(1):24-8. PubMed ID: 10025596
[TBL] [Abstract][Full Text] [Related]
33. [P21ras--a central cross-road on intracellular signalling].
Levy O; Ramot Y; Rapoport M
Harefuah; 1997 Oct; 133(7-8):304-8. PubMed ID: 9418364
[No Abstract] [Full Text] [Related]
34. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells.
Diks SH; Kok K; O'Toole T; Hommes DW; van Dijken P; Joore J; Peppelenbosch MP
J Biol Chem; 2004 Nov; 279(47):49206-13. PubMed ID: 15355981
[TBL] [Abstract][Full Text] [Related]
35. Pathway discovery: the road to Ras and MAP kinase.
Marshall C
Nat Cell Biol; 2012 Oct; 14(10):978. PubMed ID: 23033045
[No Abstract] [Full Text] [Related]
36. Normal p21Ras/MAP kinase pathway expression and function in PBMC from patients with polycystic ovary disease.
Buchs A; Chagag P; Weiss M; Kish E; Levinson R; Aharoni D; Rapoport MJ
Int J Mol Med; 2004 Apr; 13(4):595-9. PubMed ID: 15010862
[TBL] [Abstract][Full Text] [Related]
37. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria.
Confino-Cohen R; Aharoni D; Goldberg A; Gurevitch I; Buchs A; Weiss M; Weissgarten J; Rapoport MJ
J Allergy Clin Immunol; 2002 Feb; 109(2):349-56. PubMed ID: 11842308
[TBL] [Abstract][Full Text] [Related]
38. Constitutive up-regulated activity of MAP kinase is associated with down-regulated early p21Ras pathway in lymphocytes of SLE patients.
Rapoport MJ; Amit M; Aharoni D; Weiss M; Weissgarten J; Bruck N; Buchs A; Bistritzer T; Molad Y
J Autoimmun; 2002; 19(1-2):63-70. PubMed ID: 12367560
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia.
Gallagher A; Padua RA; al-Sabah A; Hoy T; Burnett AK; Darley RL
Leukemia; 1995 Nov; 9(11):1833-40. PubMed ID: 7475271
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms involved in Ras inactivation: the annexin A6-p120GAP complex.
Grewal T; Enrich C
Bioessays; 2006 Dec; 28(12):1211-20. PubMed ID: 17120209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
